| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$201,782,322 |
|
|
|
Indirect Value
|
$171,213,609 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$372,995,931 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 12 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-12-01 |
4 |
S |
$2.33 |
$6,990 |
I/I |
(3,000) |
711,858 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-11-30 |
4 |
S |
$2.36 |
$7,080 |
I/I |
(3,000) |
714,858 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-03-22 |
4 |
B |
$2.37 |
$350,155 |
I/I |
147,645 |
259,052 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-26 |
4 |
S |
$2.41 |
$54,675 |
I/I |
(22,681) |
466,666 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-11-09 |
4 |
S |
$2.41 |
$8,194 |
I/I |
(3,400) |
729,858 |
0 |
% |
|
| BDSX |
Biodesix Inc |
Director |
– • • |
2023-01-31 |
4 |
B |
$2.41 |
$24,100 |
I/I |
10,000 |
20,389,189 |
2.17 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-25 |
4 |
S |
$2.42 |
$20,345 |
I/I |
(8,394) |
489,347 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-11-28 |
4 |
S |
$2.44 |
$7,320 |
I/I |
(3,000) |
720,858 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-11-07 |
4 |
S |
$2.45 |
$7,350 |
I/I |
(3,000) |
736,258 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-04 |
4 |
S |
$2.46 |
$12,551 |
I/I |
(5,103) |
639,213 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-11-29 |
4 |
S |
$2.47 |
$7,410 |
I/I |
(3,000) |
717,858 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-11-08 |
4 |
S |
$2.49 |
$7,470 |
I/I |
(3,000) |
733,258 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-24 |
4 |
S |
$2.50 |
$27,231 |
I/I |
(10,888) |
497,741 |
0 |
% |
|
| BDSX |
Biodesix Inc |
Director |
– • • |
2023-01-27 |
4 |
B |
$2.51 |
$125,430 |
I/I |
50,000 |
20,379,189 |
2.25 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-05 |
4 |
S |
$2.52 |
$16,894 |
I/I |
(6,696) |
632,517 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-11-04 |
4 |
S |
$2.53 |
$3,542 |
I/I |
(1,400) |
739,258 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-03 |
4 |
S |
$2.54 |
$6,389 |
I/I |
(2,520) |
644,316 |
0 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-06-03 |
4 |
B |
$2.55 |
$293,482 |
D/D |
115,290 |
4,326,578 |
2.45 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-02 |
4 |
S |
$2.55 |
$901 |
I/I |
(353) |
646,836 |
0 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-06-07 |
4 |
B |
$2.56 |
$281,072 |
D/D |
110,000 |
4,562,864 |
2.45 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-12-14 |
4 |
S |
$2.58 |
$55,470 |
I/I |
(21,500) |
21,500 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-03-04 |
4 |
S |
$2.62 |
$452,570 |
I/I |
(172,717) |
4,272,777 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-23 |
4 |
S |
$2.62 |
$454 |
I/I |
(173) |
508,629 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-08 |
4 |
S |
$2.64 |
$18,014 |
I/I |
(6,824) |
625,693 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2022-08-10 |
4 |
S |
$2.65 |
$21,184 |
I/I |
(8,006) |
617,687 |
0 |
% |
|
634 Records found
|
|
Page 12 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
